BackSupernus Pharmaceuticals Overview

Supernus Pharmaceuticals Net Income

Profitability analysis for SUPN.

Quarterly Net Income

-$2.29M
↑ 80.61% YoY

As of Mar 2026

Annual Net Income (TTM)

-$29.02M
↓ 146.87% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin